The UNIVERSAL project is proud to announce the submission of a pharmacokinetic modelling and simulation analysis to the US Food and Drug Administration (FDA). This submission aims to support the new dosing of Darunavir/Ritonavir (DRV/r) 120/20mg, combined in one...
UNIVERSAL submits data to the FDA to support the dosing of a new drug combination to treat HIV in children
read more